STAT3 and pancreatic neoplasm: Boreddy et al. (2011) discovered that BITC (5–20 M) decreased the phosphorylation of STAT3 in pancreatic cancer cell lines, which was followed by a reduction in VEGF and MMP2 production, hence inhibiting angiogenesis [268].